The Product: Test What Matters. Label What’s Actually in It.

Fix the Rules, Not the Plant — Part Three

It's all about transparency in manufacturing.

If watermelon gummies and peach gummies use the exact same tested batch of THC, do we need to pretend the peach flavor created a brand-new pesticide risk?

Seems logical to test the cannabinoid input for what it may bring into the facility, then test the finished product for what manufacturing can actually change.

These are basic good manufacturing practices, and they make considerably more sense than ordering the same tests repeatedly for every flavor, shape and package size.

Test the Ingredient First

When a manufacturer receives a batch of cannabinoid oil, that input should be tested for the risks associated with it. Depending on the ingredient and how it was produced, that may include pesticides, heavy metals, residual solvents and impurities related to chemical conversion.

If the same verified batch is used in five different products, one input COA should be able to support all five.

This only works when the manufacturer preserves the batch identity, stores the ingredient properly and documents exactly which products received it.

Otherwise, it is just a lab report floating around in a folder, hoping someone remembers where the oil went.

Just because the flavor has changed doesn’t mean the cannabinoid input did.

The Chain Starts Before the Oil

The same principle applies to flower and biomass.

A cannabinoid product does not begin when a container of oil arrives at a manufacturing facility. It begins with the plant material used to create that oil.

Flower and biomass should retain their batch identity through harvest, drying, storage, transportation, processing and extraction. If one batch is divided between multiple processors, the records should show where each portion went.

If several batches are combined before extraction, the records should identify every batch included.

Flower sold directly to consumers should remain connected to its testing and production records. Biomass used for extraction should connect to the resulting extract batch, and that extract should connect to every finished product made with it.

A COA cannot simply jump over the missing parts of the supply chain.

If a problem is later found in the flower or biomass, regulators and businesses should be able to trace it forward into every affected extract and finished product. If a problem is found in a finished product, they should also be able to trace it backward to the cannabinoid ingredient, processor and original plant material.

The entire chain matters. A traceability system that starts with the finished gummy has already started too late.

Then Test What Manufacturing Can Change

Input testing does not replace finished-product testing. The two tests answer

different questions.

The finished product still needs to confirm that the potency is correct, the cannabinoid is evenly mixed, each serving is reasonably consistent and the label matches what is actually in the package.

Manufacturing may also introduce new risks. Water, food ingredients, equipment, handling, storage and packaging can affect microbial safety, stability and shelf life. Those are finished-product concerns because they may not have existed in the original cannabinoid ingredient.

The principle is simple:

Test each input for the hazards it may bring into the facility. Trace every tested batch into the products that use it. Then test the finished product for what formulation and manufacturing can change.

We do not need more testing simply for the appearance of safety. We need the right testing at the right stage.

Alcohol Already Uses Batch Logic

This is not a new concept.

Federal alcohol regulations require distilled spirits producers to maintain detailed batch records showing what ingredients were used, where they came from, which tanks they entered and where the resulting product went. Each bottling lot must connect back to the production batch.

During bottling, producers test alcohol content and fill at representative intervals and document the results. They do not send every bottle, or every flavor made from the same alcohol input, through an entirely new third-party contaminant panel.

The system relies on controlled inputs, production records, representative finished-product testing and the ability to trace each bottling lot back through the process.

Cannabinoid regulation can follow the same basic logic: document the batch, test what matters at each stage and preserve the connection from the original input to every finished product.

We already understand this approach when the regulated intoxicant is alcohol. It should not suddenly become a radical idea when the regulated intoxicant is THC.

Tell Consumers What They Are Buying

In Part Two, we asked how the THC was made. Was it extracted directly from cannabis, or was it chemically converted from CBD?

That manufacturing history should not disappear once the ingredient enters a gummy, beverage or chocolate.

“Contains hemp-derived cannabinoids” is not enough. It is technically information, in the same way that “contains food” is technically a description of dinner.

A product should identify each active cannabinoid and state the milligrams per serving and per package. Consumers should also be able to determine whether the cannabinoid was directly extracted or converted, who manufactured the ingredient and which ingredient batch was used in the finished product.

Not all of that belongs across the front of the package. It does need to remain connected to the product through its batch number and an easily accessed online record.

And by “easily accessed,” I mean three clicks or fewer.

No digital scavenger hunt. No generic testing page containing hundreds of unrelated COAs. No link to the homepage accompanied by a silent “good luck.”

Sativa Is Not an Ingredient

Manufactured products also need more honest descriptions of terpenes and flavorings.

If terpenes were added, the product should indicate whether they came from cannabis, other botanicals, a manufactured nature-identical source or a formulated blend.

The same honesty should apply to “sativa,” “indica” and “hybrid.”

A gummy does not become botanically sativa because someone added a citrus terpene blend and designed an energetic-looking package. In many manufactured products, these terms describe a marketing concept or intended experience, not the origin of the cannabinoid ingredient.

“Sativa-style citrus terpene blend” may not sound quite as magical, but it is considerably more accurate.

Terms such as “full spectrum,” “live” and “natural” should work the same way. If a company places the claim on the package, it should be able to explain what the claim means and support it with documentation.

Records Make Recalls Possible

Product and batch records are not just there to make an auditor happy. They are how manufacturers find affected products when something goes wrong.

The recent Taylor Fresh Foods jalapeño recall shows how far one ingredient can travel. Jalapeños from a recalled supply moved into dips, salsa, guacamole, sandwiches and other finished products sold under different brands and distributed across 26 states.

That is a wide reach from one ingredient.

Because the supply chain could connect that ingredient to specific finished products, companies were able to identify affected brands, UPCs, date codes, retailers and distribution areas. They did not have to recall every product containing a pepper or guess which facilities might have received it.

The FDA’s broader investigation is still ongoing, but the downstream recalls demonstrate why ingredient and batch records matter. When the records exist, a recall can be targeted. When they do not, everyone is left searching warehouses, invoices and email chains while an unsafe product may still be on the shelf.

Cannabinoid products should be no different.

If one flower, biomass or cannabinoid ingredient batch fails testing, the business should be able to identify every extract, gummy, beverage or other product connected to it, and where those products were distributed.

That is traceability doing its actual job.

The Product Should Carry Its Records

A sensible system connects the finished product all the way back to the flower or biomass, cannabinoid ingredient, processor, production method, tested input batches and final production batch.

That gives regulators something useful to inspect. It gives responsible businesses a system they can defend. It makes targeted recalls possible. Most importantly, it gives consumers more than a potency number floating in space.

We do not need to test everything repeatedly or cram an entire manufacturing record onto a gummy label.

We need to test what matters, trace what was used and label what is actually inside.